EyePoint Pharmaceuticals (EYPT) Stock Chart & Stock Price History $5.87 -0.34 (-5.48%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$5.87 0.00 (0.00%) As of 05/21/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EyePoint Pharmaceuticals Stock Price Performance The EyePoint Pharmaceuticals (EYPT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 48.82%, with a year-to-date return of -21.21%. In the past month, the stock has decreased 9.83%, reflecting recent market activity. As of the latest close, EyePoint Pharmaceuticals traded at $5.87 with a market cap of $403.92 million and volume of 690,328 shares. Five years ago, the stock traded at a split-adjusted price of $88.00, representing a 93.33% decrease over that period. At the time, it had a market cap of $109.77 million and a volume of 326,222 shares. Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.24%1 Month Performance-9.83%3 Month Performance-4.55%Year-To-Date Performance-21.21%1 Year Performance-48.82%5 Year Performance-93.33% EYPT Stock Chart for Thursday, May, 22, 2025 EYPT Chart by TradingView EyePoint Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$6.21$5.87-5.48%$6.19$5.59690,328 shs$403.92 million05/20/2025$6.10$6.21+1.80%$6.29$5.97695,713 shs$427.32 million05/19/2025$6.13$6.10-0.49%$6.27$5.75718,002 shs$419.75 million05/16/2025$5.72$6.13+7.17%$6.15$5.731.12 million shs$421.81 million05/15/2025$5.49$5.72+4.19%$5.77$5.35593,834 shs$393.60 million05/14/2025$5.91$5.49-7.11%$5.94$5.30907,138 shs$377.77 million05/13/2025$5.85$5.91+1.03%$6.00$5.78497,190 shs$406.67 million05/12/2025$5.81$5.85+0.69%$6.29$5.82537,954 shs$402.54 million05/09/2025$6.11$5.81-4.83%$6.23$5.75479,431 shs$399.79 million05/08/2025$6.09$6.11+0.25%$6.31$5.91565,574 shs$420.09 million Get the Latest News and Ratings for EYPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$6.24$6.09-2.40%$6.79$5.75825,442 shs$419.06 million05/06/2025$6.86$6.24-9.04%$6.86$6.20696,748 shs$429.38 million05/05/2025$7.30$6.86-6.03%$7.25$6.79460,264 shs$472.04 million05/02/2025$7.13$7.30+2.38%$7.45$7.06690,968 shs$502.32 million05/01/2025$6.82$7.13+4.55%$7.17$6.74584,888 shs$490.04 million04/30/2025$6.64$6.82+2.71%$6.90$6.49645,074 shs$468.73 million04/29/2025$6.78$6.64-2.06%$6.86$6.48385,575 shs$456.36 million04/28/2025$6.37$6.78+6.44%$6.91$6.38818,679 shs$465.98 million04/25/2025$6.54$6.37-2.60%$6.60$6.06805,154 shs$437.80 million04/24/2025$6.71$6.54-2.53%$6.71$6.45526,552 shs$449.49 million04/23/2025$6.51$6.71+3.07%$7.00$6.551.00 million shs$461.17 million04/22/2025$5.90$6.51+10.34%$6.51$5.97815,521 shs$447.43 million04/21/2025$5.68$5.90+3.87%$6.14$5.44510,538 shs$405.50 million Related Companies TXG Stock Price Chart TRNS Stock Price Chart ALNT Stock Price Chart LAB Stock Price Chart SENS Stock Price Chart CTKB Stock Price Chart AEHR Stock Price Chart QSI Stock Price Chart QTRX Stock Price Chart FEIM Stock Price Chart Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EYPT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EyePoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.